Our alternative 3E – Program is based on what people have actually done to survive cancer. We have learned from them and have incorporated this knowledge into our 3E program. Treating cancer with alternative strategies and without chemotherapy has become a possibility for an ever-increasing number of people.
Mesothelioma is a form of cancer caused by exposure to asbestos.To get more information about mesothelioma symptoms, diagnosis, treatment options, mesothelioma news and resources for dealing with the cancer mesothelioma or call us at 1.866.855.1229 .
The dream of any physician and consequently every patient is to receive the right treatment in the right time with cost effectiveness. To achieve this goal, the 3 pillars: evidence based medicine, clinical research innovation & resources utilization should be integrated efficiently.
In this presentation, I'll try to comprehensively review the following:
1- How are we used to perform clinical trials in Oncology?
2- Does it fits in today’s needs?
3- Integration of biology knowledge in shaping drug development
4- New Clinical trial designs “Can they offer solution for accelerating drug development?”
5- The supporting infrastructure role in clinical trial execution
Precision Medicine: Opportunities and Challenges for Clinical TrialsMedpace
The momentum and muscle behind "finding the right drug for the right patient at the right dose" has further escalated with President Barack Obama’s announcement of a $215 million dollar Precision Medicine Initiative earlier this year. In this webinar, Dr. Frank Smith will explore advances in precision medicine and how it is affecting clinical research. As a pediatric hematologist/oncologist, he will use his extensive clinical and research background as a backdrop for the discussion.
Topics will include:
The evolution of "personalized medicine" to "precision medicine"
How state-of-the-art molecular biology is creating new diagnostic and prognostic strategies
How these new strategies are helping inform the design of clinical trials
Case study: How precision medicine is improving clinical trials in hematology and oncology
Mesothelioma is a form of cancer caused by exposure to asbestos.To get more information about mesothelioma symptoms, diagnosis, treatment options, mesothelioma news and resources for dealing with the cancer mesothelioma or call us at 1.866.855.1229 .
The dream of any physician and consequently every patient is to receive the right treatment in the right time with cost effectiveness. To achieve this goal, the 3 pillars: evidence based medicine, clinical research innovation & resources utilization should be integrated efficiently.
In this presentation, I'll try to comprehensively review the following:
1- How are we used to perform clinical trials in Oncology?
2- Does it fits in today’s needs?
3- Integration of biology knowledge in shaping drug development
4- New Clinical trial designs “Can they offer solution for accelerating drug development?”
5- The supporting infrastructure role in clinical trial execution
Precision Medicine: Opportunities and Challenges for Clinical TrialsMedpace
The momentum and muscle behind "finding the right drug for the right patient at the right dose" has further escalated with President Barack Obama’s announcement of a $215 million dollar Precision Medicine Initiative earlier this year. In this webinar, Dr. Frank Smith will explore advances in precision medicine and how it is affecting clinical research. As a pediatric hematologist/oncologist, he will use his extensive clinical and research background as a backdrop for the discussion.
Topics will include:
The evolution of "personalized medicine" to "precision medicine"
How state-of-the-art molecular biology is creating new diagnostic and prognostic strategies
How these new strategies are helping inform the design of clinical trials
Case study: How precision medicine is improving clinical trials in hematology and oncology
Michael K. Wong, MD, PhD, provides an update on immunotherapy in melanoma at the 2017 MD Anderson Melanoma Patient Symposium held in Austin, TX on May 6, 2017.
Audio and slides for this presentation are available on YouTube: http://youtu.be/NzJ_fvSxwGk
Sara Tolaney, MD, MPH, a breast oncologist with the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute, gives an overview of phase I clinical trials and some of the new drugs being tested to treat breast cancer. This talk was originally given at the Metastatic Breast Cancer Forum at Dana-Farber on Oct. 5, 2013.
The maturation of genomic technologies has enabled new
discoveries in disease pathogenesis as well as new approaches to patient care.
In pediatric oncology, patients may now receive individualized genomic analysis to identify molecular aberrations of relevance for diagnosis and/or treatment.
Several recent clinical studies have begun to explore the feasibility and utility of genomics-driven precision medicine.
2015 06-02 Steering group 'Personalized Medicine: eligible or not'Alain van Gool
Update for the steering group of the project "Personalized Medcine: eligble or not?", aiming to define whether and how to implement pharmacogenetic screening by first line care practitioners.
Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...CrimsonpublishersCancer
As Personalized Medicine tailored the field of precision oncology, many challenges have been arising to fulfill the dream of a full personalized health integrated system in cancer therapy. Personalized oncology has been addressed through the past decades in multiple disease and various stages using high throughput technology. This review gives hand on recent advances of personalized oncology in several cancer disease models including leukemia, melanoma, breast cancer, lung cancer, colorectal cancer, and prostate cancer. Moreover, the review enumerates technology-based assessment of personalized biomarkers, including chip micro-array, organ on chip, and next generation sequencing. Meanwhile addressing challenges faced in implementing true personalized health cancer in oncology setting, this review focuses on bridging the gap between omics data analytics and epidemiology to overcome the true challenge of direct application.
Audio and slides for this presentation are available on YouTube: http://youtu.be/7iFnx9y_cCw
Arnie Freedman, MD, clinical director of the Dana-Farber/Brigham and Women's Cancer Center Adult Lymphoma Program, discusses several options for maintenance therapy of lymphoma, and the pros and cons of each. This presentation was originally given at the Lymphoma Research Foundation's 2013 North American Forum on Sept. 29, 2013. http://www.dana-farber.org | http://www.lymphoma.org
Immunotherapy for Metastatic Triple Negative Breast Cancerbkling
Sylvia Adams, MD, medical oncologist, and associate professor at the NYU School of Medicine, discusses the latest research including the role of immunology in the treatment of triple negative metastatic breast cancer. This webinar was hosted on October 19, 2016.
The global precision medicine market has benefitted greatly from advancements in the life science industry. Although in its nascent stage, targeted therapies hold high chances of becoming a massive success in the coming years because of the potential to treat and cure chronic illnesses. The market is thus expected to expand at a compound annual growth rate (CAGR) of 11.60% between 2018 and 2023, generating USD 88.25 Bn in revenue by 2023.
An overview of Clinical Trials for Metastatic HER2-positive Breast Cancer by Dr. Ian Krop, MD, PhD, Chief and Clinical Research Director, Breast Oncology Center at Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute
Michael K. Wong, MD, PhD, provides an update on immunotherapy in melanoma at the 2017 MD Anderson Melanoma Patient Symposium held in Austin, TX on May 6, 2017.
Audio and slides for this presentation are available on YouTube: http://youtu.be/NzJ_fvSxwGk
Sara Tolaney, MD, MPH, a breast oncologist with the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute, gives an overview of phase I clinical trials and some of the new drugs being tested to treat breast cancer. This talk was originally given at the Metastatic Breast Cancer Forum at Dana-Farber on Oct. 5, 2013.
The maturation of genomic technologies has enabled new
discoveries in disease pathogenesis as well as new approaches to patient care.
In pediatric oncology, patients may now receive individualized genomic analysis to identify molecular aberrations of relevance for diagnosis and/or treatment.
Several recent clinical studies have begun to explore the feasibility and utility of genomics-driven precision medicine.
2015 06-02 Steering group 'Personalized Medicine: eligible or not'Alain van Gool
Update for the steering group of the project "Personalized Medcine: eligble or not?", aiming to define whether and how to implement pharmacogenetic screening by first line care practitioners.
Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...CrimsonpublishersCancer
As Personalized Medicine tailored the field of precision oncology, many challenges have been arising to fulfill the dream of a full personalized health integrated system in cancer therapy. Personalized oncology has been addressed through the past decades in multiple disease and various stages using high throughput technology. This review gives hand on recent advances of personalized oncology in several cancer disease models including leukemia, melanoma, breast cancer, lung cancer, colorectal cancer, and prostate cancer. Moreover, the review enumerates technology-based assessment of personalized biomarkers, including chip micro-array, organ on chip, and next generation sequencing. Meanwhile addressing challenges faced in implementing true personalized health cancer in oncology setting, this review focuses on bridging the gap between omics data analytics and epidemiology to overcome the true challenge of direct application.
Audio and slides for this presentation are available on YouTube: http://youtu.be/7iFnx9y_cCw
Arnie Freedman, MD, clinical director of the Dana-Farber/Brigham and Women's Cancer Center Adult Lymphoma Program, discusses several options for maintenance therapy of lymphoma, and the pros and cons of each. This presentation was originally given at the Lymphoma Research Foundation's 2013 North American Forum on Sept. 29, 2013. http://www.dana-farber.org | http://www.lymphoma.org
Immunotherapy for Metastatic Triple Negative Breast Cancerbkling
Sylvia Adams, MD, medical oncologist, and associate professor at the NYU School of Medicine, discusses the latest research including the role of immunology in the treatment of triple negative metastatic breast cancer. This webinar was hosted on October 19, 2016.
The global precision medicine market has benefitted greatly from advancements in the life science industry. Although in its nascent stage, targeted therapies hold high chances of becoming a massive success in the coming years because of the potential to treat and cure chronic illnesses. The market is thus expected to expand at a compound annual growth rate (CAGR) of 11.60% between 2018 and 2023, generating USD 88.25 Bn in revenue by 2023.
An overview of Clinical Trials for Metastatic HER2-positive Breast Cancer by Dr. Ian Krop, MD, PhD, Chief and Clinical Research Director, Breast Oncology Center at Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...Ruchi Vahi
The exploration of clinical trials has become increasingly important in the medical field, with each trial providing insight into how we can better detect, diagnose and treat diseases. In this article, we will be looking at the different aspects of clinical research and trial processes, as well as discussing the importance of these studies in advancing healthcare treatments.
Visit us: https://mprex.in/project/late-phase-clinical-trials-and-research/
The outlook for cancer treatment options is a promising one. Researchers and physicians are discovering new ways to identify the best care for patients through targeted treatments. With the large number of cancer types, a treatment plan that works well for one person may not be the best plan for another. Through collaboration, rapidly evolving technology, and research in genetics and the molecular profiling of tumors, researchers and physicians have made astounding strides in the development of personalized cancer care.
How to have quality of life in Advanced ovarian malignancyRajesh Gajbhiye
Presentation given by Dr Rakhi Gajbhiye, Mauli Hospital Nagpur at MGIMS sewagram for an International conference on Womens Health Fatal Disorders Survival with Quality in collaboration with FOGSI.
This was the function to commemorate 100 th birth centenary of Dr Sushila
We know that mesothelioma patients would rather stay local when receiving treatment,rnso we will review options for private medical centers, surgical consultants, clinical trials,rnand match you up with friendly, local physicians wherever we can.
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docxcowinhelen
Running head: INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS 1
INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS 18
Ineffective Cancer treatments leading to deaths
Name
Course
Tutor
Date
Abstract
The main focus of the report will be to research on the various methods through which cancer can be treated with a keen eye on why some methods are ineffective and lead to death. A discussion on different cancer treatment will be done followed by the types of cancer that cause millions of death today. Presentation of answers to the research questions will be done in line with ineffective cancer treatment methods. Relevant literature review will be conducted and used to support the claims of ineffective cancer treatments. Lastly, recommendations on the best cancer treatment will be done.
Introduction
Cancer is an ailment caused by the unrestrained division of abnormal cells in the body. The cancer cells are malignant meaning they can spread from the origin to distant organs and tissues. The disease can be genetically hereditary hence can be crossed over from one generation to another. Some of the forms of cancer treatment include targeted therapy, hormone therapy, chemotherapy, precision medicine, surgery, immunotherapy, and stem cell transplant. Some of the common types of this disease include lung, liver, stomach, and bowel cancers.
Cancer is also called as malignancy which means abnormal cells growth. More than 100 types of cancer are found in this world today, including breast cancer (widely spread among women), skin cancer (found in the person of almost every age), lung cancer (common among smokers), colon cancer, lymphoma and prostate cancer. Each kind of cancer has varying symptoms. Cancer differs with respect to the cell it affects first. The uncontrollable division of cells harm the body and form lumps and the masses of tissues which are known as tumors. The tumor grows in size and sometimes even intervene the digestive system, circulatory system, excretory system and nervous system. In the case of leukemia, cancer inhibits the normal blood functioning which is caused due to the abnormal cell division into the blood stream. Cancer also causes the systems of the body to secrete hormones that alter the body functioning. Tumors that do not grow and remain limited to one spot are considered to slightly less harmful and benign. The sign of the more dangerous and malignant cells is:
1. The harmful cancerous cells move from one spot to another throughout the body using blood as a medium and invade the organs and the healthy tissues of the body.
2. These cells grow and divide rapidly, they make blood vessels of their own which are used by them in the process of feeding, called as angiogenesis.
Then comes a stage is known as metastasized in which the tumor spread successfully to the other parts of the body, penetrating into the healthy tissues of the body and damaging them badly. The process is known as metastasis. It cause ...
We know that mesothelioma patients would rather stay local when receiving treatment,rnso we will review options for private medical centers, surgical consultants, clinical trials,rnand match you up with friendly, local physicians wherever we can.
We know that mesothelioma patients would rather stay local when receiving treatment,rnso we will review options for private medical centers, surgical consultants, clinical trials,rnand match you up with friendly, local physicians wherever we can.
We know that mesothelioma patients would rather stay local when receiving treatment,rnso we will review options for private medical centers, surgical consultants, clinical trials,rnand match you up with friendly, local physicians wherever we can.
We know that mesothelioma patients would rather stay local when receiving treatment,rnso we will review options for private medical centers, surgical consultants, clinical trials,rnand match you up with friendly, local physicians wherever we can.
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
As a business owner in Delaware, staying on top of your tax obligations is paramount, especially with the annual deadline for Delaware Franchise Tax looming on March 1. One such obligation is the annual Delaware Franchise Tax, which serves as a crucial requirement for maintaining your company’s legal standing within the state. While the prospect of handling tax matters may seem daunting, rest assured that the process can be straightforward with the right guidance. In this comprehensive guide, we’ll walk you through the steps of filing your Delaware Franchise Tax and provide insights to help you navigate the process effectively.
Remote sensing and monitoring are changing the mining industry for the better. These are providing innovative solutions to long-standing challenges. Those related to exploration, extraction, and overall environmental management by mining technology companies Odisha. These technologies make use of satellite imaging, aerial photography and sensors to collect data that might be inaccessible or from hazardous locations. With the use of this technology, mining operations are becoming increasingly efficient. Let us gain more insight into the key aspects associated with remote sensing and monitoring when it comes to mining.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
"𝑩𝑬𝑮𝑼𝑵 𝑾𝑰𝑻𝑯 𝑻𝑱 𝑰𝑺 𝑯𝑨𝑳𝑭 𝑫𝑶𝑵𝑬"
𝐓𝐉 𝐂𝐨𝐦𝐬 (𝐓𝐉 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬) is a professional event agency that includes experts in the event-organizing market in Vietnam, Korea, and ASEAN countries. We provide unlimited types of events from Music concerts, Fan meetings, and Culture festivals to Corporate events, Internal company events, Golf tournaments, MICE events, and Exhibitions.
𝐓𝐉 𝐂𝐨𝐦𝐬 provides unlimited package services including such as Event organizing, Event planning, Event production, Manpower, PR marketing, Design 2D/3D, VIP protocols, Interpreter agency, etc.
Sports events - Golf competitions/billiards competitions/company sports events: dynamic and challenging
⭐ 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬:
➢ 2024 BAEKHYUN [Lonsdaleite] IN HO CHI MINH
➢ SUPER JUNIOR-L.S.S. THE SHOW : Th3ee Guys in HO CHI MINH
➢FreenBecky 1st Fan Meeting in Vietnam
➢CHILDREN ART EXHIBITION 2024: BEYOND BARRIERS
➢ WOW K-Music Festival 2023
➢ Winner [CROSS] Tour in HCM
➢ Super Show 9 in HCM with Super Junior
➢ HCMC - Gyeongsangbuk-do Culture and Tourism Festival
➢ Korean Vietnam Partnership - Fair with LG
➢ Korean President visits Samsung Electronics R&D Center
➢ Vietnam Food Expo with Lotte Wellfood
"𝐄𝐯𝐞𝐫𝐲 𝐞𝐯𝐞𝐧𝐭 𝐢𝐬 𝐚 𝐬𝐭𝐨𝐫𝐲, 𝐚 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. 𝐖𝐞 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐚𝐭 𝐬𝐡𝐨𝐫𝐭𝐥𝐲 𝐲𝐨𝐮 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐭𝐨𝐫𝐢𝐞𝐬."
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
What is the TDS Return Filing Due Date for FY 2024-25.pdfseoforlegalpillers
It is crucial for the taxpayers to understand about the TDS Return Filing Due Date, so that they can fulfill your TDS obligations efficiently. Taxpayers can avoid penalties by sticking to the deadlines and by accurate filing of TDS. Timely filing of TDS will make sure about the availability of tax credits. You can also seek the professional guidance of experts like Legal Pillers for timely filing of the TDS Return.
Enterprise Excellence is Inclusive Excellence.pdfKaiNexus
Enterprise excellence and inclusive excellence are closely linked, and real-world challenges have shown that both are essential to the success of any organization. To achieve enterprise excellence, organizations must focus on improving their operations and processes while creating an inclusive environment that engages everyone. In this interactive session, the facilitator will highlight commonly established business practices and how they limit our ability to engage everyone every day. More importantly, though, participants will likely gain increased awareness of what we can do differently to maximize enterprise excellence through deliberate inclusion.
What is Enterprise Excellence?
Enterprise Excellence is a holistic approach that's aimed at achieving world-class performance across all aspects of the organization.
What might I learn?
A way to engage all in creating Inclusive Excellence. Lessons from the US military and their parallels to the story of Harry Potter. How belt systems and CI teams can destroy inclusive practices. How leadership language invites people to the party. There are three things leaders can do to engage everyone every day: maximizing psychological safety to create environments where folks learn, contribute, and challenge the status quo.
Who might benefit? Anyone and everyone leading folks from the shop floor to top floor.
Dr. William Harvey is a seasoned Operations Leader with extensive experience in chemical processing, manufacturing, and operations management. At Michelman, he currently oversees multiple sites, leading teams in strategic planning and coaching/practicing continuous improvement. William is set to start his eighth year of teaching at the University of Cincinnati where he teaches marketing, finance, and management. William holds various certifications in change management, quality, leadership, operational excellence, team building, and DiSC, among others.
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...PaulBryant58
This article provides a comprehensive guide on how to
effectively manage the convert Accpac to QuickBooks , with a particular focus on utilizing online accounting services to streamline the process.
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
Improving profitability for small businessBen Wann
In this comprehensive presentation, we will explore strategies and practical tips for enhancing profitability in small businesses. Tailored to meet the unique challenges faced by small enterprises, this session covers various aspects that directly impact the bottom line. Attendees will learn how to optimize operational efficiency, manage expenses, and increase revenue through innovative marketing and customer engagement techniques.
1. 10 11
What was the study about?
From June 30, 2008, to March 30, 2009, 73 can-
cer patients participated in a five-week program
at the 3E-Centre in Germany. The 3E-Center is
neither a hospital, a clinic, nor a hotel. It is a
place where most terminal cancer patients can
learn the 3E-program of Lothar Hirneise, the
renowned German cancer advocate and sole
student of the famous Dr. Johanna Budwig, with
whom the “Flaxseed Lady” wrote two books and
presented several speeches together.
Six of these 73 patients came to the 3E-Centre
post-tumor surgery and had not procured further
conventional therapies before. At the time of
admission, all of the remaining 67 patients had
conventionally-diagnosed tumors. Nineteen
of these patients had inoperable tumors
while 16 patients had an R0-resection, but
with recurrences. Thirty-two, on the other
hand, had undergone surgery and had been
treated with chemotherapy and/or radiation
but experienced recurrences as well.
Two years later, 36 (53%) of the 67 patients, all
of whom had an average lifespan of six months,
were still living. Seven patients, with partly
multiple metastases, as well as one with inoper-
able glioblastoma were free of tumors. Fifteen
patients had a stable disease without further
tumor growth while the PETs of two patients
with a pancreatic carcinoma revealed normal
Standardized Uptake Values (SUVs). Although
the SUVs indicated no tumor-mass, the measure-
ments revealed a significant decrease in tumor
activity. Only three patients of the 36 reported
feeling worse at the end of the study than at
their discharge. Lastly, the six patients having
arrived free of tumors felt very well with no
relapses.
To the layman, these figures may sound unspec-
tacular, but when you go into detail, they are
extraordinary for various reasons.
1.
First of all, one out of every two patients was
still alive after two years despite being given an
average life expectancy of 6 months. The usual
excuse of conventional doctors such as “sponta-
neous remissions” or “rare miracle cures” do not
help here either as these are typically found only
in one patient of 100,000 and not at an incred-
ible 50%.
There is
always hope
by Marta Zaraskah
53%
SURVIVORS!
How many similar
studies do you know
with end-stage
cancer patients?
2010, a study was pub-
lished in Germany under
the inconspicuous
name: The 3E-program
in Combination with Papimi instead
of Palliative Intervention. Perhaps
it was the nomenclature or the
fact that this study never appeared
in any peer-reviewed journal,
that it never received the atten-
tion it deserved. In any case, I am
unaware of any other study with
such good results. Hence, I took the
time to take a closer look at the
3E-program.
The 3E-Program -
probably the world’s
most succesful
cancer therapy for
end-stage cancer
patients.
In
2. 12 13
Dr. Johanna Budwig and Lothar Hirneise
The 3E program
is based on the
analysis of case
histories of thou-
sands of people
who have survived
late stage cancer.
3E-CENTER
GERMANY
LEARNING
FROM
PEOPLE
WHO
SURVIVED
CANCER
2.
Eight patients who had multiple metastases or
an inoperable brain tumor just two years ear-
lier were completely tumor-free by the end of
the study. These results are extremely unusual
because the patients were considered tradition-
ally incurable. Even if only these eight patients
survived, the study would still have been a great
success. It should be noted that if these patients
had been treated conventionally
with more chemotherapy and irradiation, 100%
would have died.
3.
Fifteen patients had a stable disease which
means these patients have already lived three
times longer than their doctors previously pre-
dicted. Additionally, these fifteen experienced a
cessation in tumor growth.
4.
Two patients with pancreat-
ic cancer were free of active
tumors indicated by their PETs
but were still visible in their
CTs. At that time, the radiolo-
gist in charge wrote in his
report that he had never seen
anything like this before and
recommended the patient to
continue with their therapy, no
matter what it was. It should
also be noted that the survival
rate of patients with pancreatic
cancer after two years is usu-
ally at 1-2%. Those aware of
this survival rate are better at
estimating these cases.
If any drug can produce even
roughlysimilar (healing) results,
the pharmaceutical company in
possession of said drug can
potentially earn billions. And
yet, the 3E-program is rela-
tively unknown. Unfortunately,
we’re still a long way from
seeing doctors and researchers
who move outside the main-
stream receive the attention
they deserve despite living in
the 21st century. Furthermore,
the official news on TV and
print media still rely heavi-
ly on arbitrary sponsors and
donors such as politicians, their
political parties, and members.
Social networks are no help
as well; filled to the brim with
millions of so-called experts
that make it nigh-impossible
for the real experts to separate
the wheat from the chaff.
It is not really surprising then
that the 3E-program remains
obscure, if not ridiculed or
discredited as pseudoscience
despite its proven successes.
Instead, millions of cancer
patients are persuaded to take
palliative therapies, such as
chemotherapy, every year.
Interestingly, doctors often
seemingly forget to inform
cancer patients, especial-
ly later stages, that pallia-
tive therapies are meant to
bring relief until the end of
life but not cure. This appar-
ent omission would then lead
patients to misunderstand the
treatment to be curative and
believe that at some point they
will become healthy again. In
reality, the actual intent of pal-
liative care is pain relief
without addressing
the cause of the
condition.
Consequently, the therapy or
treatment is procured because
no other option is available or
presented to the patient. Worse
yet, the patient is kept in the
dark if it means the physician
will earn money from the treat-
ment.
Faith, knowledge, or logic?
Many patients believe they
have no choice but to trust
their doctor, at times blindly,
because of the extensive expe-
rience and knowledge physi-
cians have acquired through
much study and training. In
addition, doctors own a veri-
table 007 license to kill or in
other words,“if a cancer patient
dies, the doctor or the therapy
is never guilty or at fault” and
that “the cancer just proved to
be stronger.”
3. 14 15
THE 3E-CENTRE IS ONE OF THE TOP
13 ALTERNATIVE CANCER CLINICS IN GERMANY!
Holistic dentistry can
be very important
The highly effective ORIGINAL Oil-Protein Diet, created by the dis-
tinguished scientist Dr. Johanna Budwig, stands alongside other
effective therapies, to form the heart of the 3E-Program.
This shared madness, affectionately called folie à
deux by the French, has meanwhile reached such
proportions that the chemotherapeutic agent
gemcitabine, for instance, is still used on pancre-
atic cancer – a therapy that fails in about 96% of
patients. However, since other chemotherapies
are even worse, many acquiesce to the use of
gemcitabine.
Instead of considering different therapy
options, however, the dogma maintains that
chemotherapy is the best cancer therapy despite
now being almost completely unsuccessful at
certain stages or against certain types of cancer,
including pancreatic cancer. Still, many believe
that it is better to publish the success of che-
motherapy in medical journals and yellow press
magazines even with the many studies available
that point to the ineffectiveness of these thera-
pies in the treatment of tumors such as epithe-
lial tumors –which make up 90% of all tumors.
This insidious method and effective tactic is
a key reason why most patients, and even some
doctors, are unable to analyze and understand
all the facts correctly. What’s more, people who
hear completely different opinions are inclined
to follow the mainstream which in our case is
university medicine.
But what does this mean for a cancer patient?
Where, if not from the doctor or from the com-
mon media, should patients receive the nec-
essary information? Who else can they trust?
Unfortunately, this is not a simple question to
answer.We should, perhaps, flip the question and
instead ask: “Who can’t you trust?”
Bear in mind that some procedures may sound
appealing at first, but upon closer inspection,
isn’t always the case. Many NGO organizations
proclaim effective alternative cancer therapies
and that they are independent. Unfortunately,
however, these organizations are no better than
conventional studies at providing sound proof
on the efficacy of chemotherapy. Ultimately, can-
cer patients are, logically, only interested in one
question:
Will this treatment help me improve as
opposed to doing nothing?
It may be hard to believe, but it’s this very ques-
tion that’s never addressed nor answered in all
the thousands of studies available. Why not?
Let me explain. Studies typically involve two
groups. The first group will receive a specific
therapy while the second group will not. For
you to know if a particular treatment will help
you, there must be a clear difference between
the two groups at the aftermath of the study:
the group that received treatment must indi-
cate a clear improvement in
health and overall quality of
life. However, the placebo stud-
ies, normally present in other
faculties of medicine, do not
exist in oncology. Universities
and pharma companies try to
ascribe the lack of such stud-
ies to ethical reasons, that it is
impossible to give one group
chemotherapy while another
group receives a placebo or an
alternative therapy.
Think about it: these orga-
nizations have established a
system where they deem ethi-
cal the use of the terrible poi-
son derived from mustard gas
(cyclophosphamide) for treat-
ment but not, for instance,
High-Dose Intravenous Vitamin
C (IVC) therapy with similar
cytostatic functions while being
nearly free of side effects. Thus,
is the crazy medical world that
is oncology. Consequently, the
main question cancer patients
have has never been answered
until today, that is, by the titular
study in oncology.
Coincidentally, alternative
therapies also suffer from a
lack of double-blind studies
due to lack of funding or sup-
port from universities. In the
current state, the only question
that conventional doctors can
answer is whether one type of
chemotherapy is better than
another. Meanwhile, alternative
doctors can only explain why a
patient should pursue a particu-
lar therapy and how said thera-
py works. I was quite frustrated
when this problem dawned on
me. Nevertheless, this realiza-
tion helped me understand the
sad reality present in oncology
more clearly and also enabled
me to judge better the appro-
priate therapy one should pro-
cure. The following tips I’ll be
sharing will help you find the
best therapy for your condition.
First of all,you’ll need to decide
whether to follow a conven-
tional route or an alternative
one.
I know that being told “one can
have the best of both worlds”
sounds veryappealing to cancer
patients.However,this is a com-
mon misconception. Pursuing
both therapy groups is similar
4. 16 17
Incidentally, if you believe that
tumor cells are not inherently
evil but rather a part of you
– the outcome of the life you
have led – then you should
opt for one or more alternative
therapies that may or may not
require surgery.
Due to the scarce num-
ber of helpful studies available,
one is left with their critically
and logically thinking mind.
For instance, I, personally, never
doubted conventional medi-
cine, that is until I heard a
lecture that raised the issue
in making a person extremely
ill with toxins so that they can
become healthy. This thought
was incredibly logical to me
that it changed my medical
thinking completely. Looking
now at the 3E-program by
Lothar Hirneise, logically, the
results of their study are no
longer surprising. I’ll describe
the principles mentioned in the
3E study below.
1. Always a curative approach
The3E-programis,firstandfore-
most, a fundamentally curative
approach. Both the therapist
and the patient should believe
that the applied is not palliative.
Additionally, life-prolonging
treatments should not be used.
I can agree with this approach
especially so since modern pla-
cebo research proves its valid-
ity today and so I’m entirely
compliant. Furthermore, this
particular view effectively rais-
es the question: “Why are end-
stage therapies that eventually
lead to loss of life still created/
favored?” It’s about time we
rethink the entire palliative
approach in oncology.
2. Detoxification over
poisoning
I can personally confirm that
the 3E-program follows this
particular approach absolutely.
It’s quite incredible that can-
cer patients today are poisoned
with all kinds of drugs but
detoxification therapies are
utterly absent or never pre-
scribed. Incidentally, this unfor-
tunate situation is not limited
to chemotherapy but nearly all
other prescription drugs.
3. Nutritional therapy is the
basis of the treatment
The 3E-program includes the
Original Oil-Protein Diet of Dr.
Johanna Budwig as its basic
nutritional therapy. In his writ-
ings and lectures, however,
Lothar Hirneise repeatedly
emphasizes that a raw food or
the Gerson Diet will also be
suitable. The disbelief exhib-
ited by oncologists in the sig-
nificance of nutritional thera-
pies has always shocked me.
Nonetheless, I do agree with
the approach that all cancer
therapies should include some
form of nutritional therapy.
to driving a car by simultaneously accelerating and braking: you’ll get nowhere, and you might even
damage the engine. Also, try to avoid the popular thinking that “If trying conventional medicine
doesn’t work, I can just pursue alternative medicine.”Take note that if you try one therapy group first
– say conventional treatment with their chemotherapy, radiation, and possibly surgery– you will not
be the same person post-treatment and the alternative therapy that may have helped you initially
no longer has the same appeal.
Secondly, you have a powerful
weapon at your disposal: logic.
Use it!
If you firmly believe a tumor
to be bad and you need to
kill or sever the evil then, by
all means, have an operation.
Eventually, you’ll also have to
undergo chemotherapy and
radiation. Before chemo, you’ll
have to submit to a chemo-
sensitivity test. Such a test will
partly determine the chemo-
therapy program that suits your
condition best and those that
are unsuitable. This informa-
tion, by itself, will be invaluable.
However, remember that radia-
tion therapy will not leave you
unscathed as some may think.
To be sure, damage to the body
should be expected. Hence, take
particular care if you plan to
follow a radiation therapy with
doses above 50 gray (Gy) as it
takes just 0.5 Gy to induce the
production of new cancer cells.
If a tumor has been completely
removed from healthy tissue
(R0 operation), then the ques-
tion on what is to be irradiated
should be asked. In most cases,
the argument is raised on the
issue of micrometastases – the
possibility that the cancer has
spread in minuscule amounts
to other tissue. Unfortunately,
the observation of microme-
tastases under a microscope
has not been accomplished
until today. The notion is quite
questionable since it only pre-
vails today due to an unproven
theory on creating irradiation
therapy which ultimately has
been proven to be carcinogenic.
5. 18
4. Energetic programs and life changes
If you believe random DNA alternations are
responsible for cancer, then by all means,
continue following the lifestyle you’ve led up
to your diagnosis. On the other hand, if you
believe as I do, that influencing genes is pos-
sible and that there are physical and psycho-
logical reasons for cancer, then you’ll under-
stand the significance of life changes post-
diagnosis. In this method lies the strength of
the 3E-program bolstered by the consistent
implementation of the Oil-Protein Diet.
Lothar Hirneise and Klaus Pertl, the found-
ers of the 3E-Centre, repeatedly stress in their
writings and lectures the utmost importance
of finding the Whys behind cancer. According
to Hirneise and Pertl, this search must come
first while the eradication of a tumor, only
second.
5. Discipline is necessary
With all the strict routines and schedules,
major dietary adjustments, daily detoxi-
fication therapies; as well as an honest
self-examination of one’s life to necessitate
changes, one thing is certain: self-discipline
is an absolute necessity. Undoubtedly, the dis-
cipline we speak of will take years of practice
and, interestingly, may prove even more diffi-
cult for the patient than chemotherapy. In my
personal experience with cancer patients, one
also needs strict discipline. Sadly, not many
cancer patients have the luxury of time to
undergo therapy for months or years.
Why is the 3E-program so successful with
end-stage patients?
I believe that the key to the 3E-Program if
there is one at all, is this: the combination
of the search for the Whys – the reasons and
causes - behind the disease takes the high-
est priority while tumor eradication is kept in
second place and that it is the only place in
the world where the Original Budwig Protocol
is consistently performed. While many claim
to teach the Budwig Protocol, it is celebrated
in detail at the 3E Center.
Conversely, all conventional treatments
and most alternative therapies focus entirely
on the tumor and its eradication. However,
nearly all of these therapies are at a disad-
vantage since their main goal is the treat-
ment of a symptom – the tumor – but not the
underlying disease.
Metastases and second or even third
tumors have developed resistance to conven-
tional and alternative cell-destroying thera-
pies. When addressing end-stage cancer, only
a deep understanding of the Whys, coupled
with a focus on a healthy body (detoxifica-
tion, Oil-Protein Diet ...) and a sound mind,
(meditation, anti-stress training, visualization,
3E - goal setting program, synergetik, psycho-
bionik, ...) can lead to healthier future.
I hope that other clinics and doctors will
be able to understand and appreciate the
findings of the 3E-Program and in the future
achieve similar successes with end-stage
cancer patients similar to the findings at the
3E-Centre in Germany.
More informations: www.3e-centre.com * www.hirneise.com
www.3e-program.com * www.oilproteindiet.com * www.iopdf.com